Review ArticleReview

Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer

Meng Zhang, Ergang Liu, Yanna Cui and Yongzhuo Huang
Cancer Biology & Medicine August 2017, 14 (3) 212-227; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0054

Article Information

vol. 14 no. 3 212-227
DOI 
https://doi.org/10.20892/j.issn.2095-3941.2017.0054
Published By 
Cancer Biology & Medicine
History 
  • Received May 4, 2017
  • Accepted July 3, 2017
  • Published online August 1, 2017.
Copyright & Usage 
Copyright: © 2017, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Author Information

  1. Meng Zhang1,2,*,
  2. Ergang Liu1,3,*,
  3. Yanna Cui1,4 and
  4. Yongzhuo Huang⇑1,2
  1. 1Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
  2. 2University of Chinese Academy of Sciences, Beijing 100049, China
  3. 3State Key Laboratory of Chemical Engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China
  4. 4Key Laboratory of Primate Neurobiology, Institute of Neuroscience, Chinese Academy of Sciences, Shanghai 200031, China
  1. Correspondence to: Yongzhuo Huang, E-mail: yzhuang{at}simm.ac.cn
View Full Text
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords